Back to Search Start Over

Clinical Evaluation of a Hydrophobic Intraocular Lens Using a Preloaded Automated Injector in a Korean Population

Authors :
Kim,Hong Kyun
Seo,Kyoung Yul
Yoon,Kyung Chul
Choi,Chul Young
Chung,Tae-Young
Hyon,Joon Young
Rendon,Alexis
Kim,Hyun Seung
Kim,Hong Kyun
Seo,Kyoung Yul
Yoon,Kyung Chul
Choi,Chul Young
Chung,Tae-Young
Hyon,Joon Young
Rendon,Alexis
Kim,Hyun Seung
Publication Year :
2023

Abstract

Hong Kyun Kim,1 Kyoung Yul Seo,2 Kyung Chul Yoon,3 Chul Young Choi,4 Tae-Young Chung,5 Joon Young Hyon,6 Alexis Rendon,7 Hyun Seung Kim8 1Department of Ophthalmology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; 2Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine; Cornea Dystrophy Research Institute, Seoul, Republic of Korea; 3Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea; 4Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 5Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 6Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea; 7Alcon Vision LLC, Fort Worth, TX, USA; 8Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaCorrespondence: Hyun Seung Kim, Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Email sara514@catholic.ac.krPurpose: This study assessed post-market clinical outcomes of the Clareon monofocal intraocular lens (IOL) preloaded in the AutonoMe Delivery System in a real-world setting of Korean patients.Methods: This prospective, multicenter, single-arm study in Korea was conducted from July 2020 to December 2021. Patients were ≥ 20 years old with unilateral or bilateral cataracts who received Clareon IOLs (CNA0T0) preloaded in an automated injector system. Best corrected distance visual acuity (BCDVA) and uncorrected distance visual acuity (UCDVA) were evaluated under photopic conditions. Surgeon delivery system preference was assessed using a survey questionnaire

Details

Database :
OAIster
Notes :
text/html, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1409451639
Document Type :
Electronic Resource